Id	1113
VARIANT_NAME	Amplification
GENE_NAME	ERBB2
EVIDENCE_RATING	4
EVIDENCE_LEVEL	A
CERTANITY	HIGH
DISEASE_NAME	Her2-receptor Positive Breast Cancer
DRUG_NAMES	Neratinib, Trastuzumab, 
SOURCE_SOURCE_TYPE	PUBMED
DATE_SYNCHRONIZED	2022-11-03 22-04-35